Radiotherapy & Oncology
Volume 94, Issue 1 , Pages 12-23 , January 2010

Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy

  • Alfredo Polo

      Affiliations

    • Ramon y Cajal University Hospital, Madrid, Spain
    • ,
  • Carl Salembier

      Affiliations

    • Department of Radiation Oncology, Europe Hospitals, Brussels, Belgium
    • ,
  • Jack Venselaar

      Affiliations

    • Department of Radiotherapy, Dr B. Verbeeten Institute, Tilburg, The Netherlands
    • ,
  • Peter Hoskin

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK
    • Corresponding Author InformationCorresponding author. Address: Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK.
    • ,
  • on behalf of the PROBATE group of the GEC ESTRO

Received 26 April 2009 ,Revised 28 November 2009 ,Accepted 21 December 2009.

References 

  1. Goharderakhshan RZ, Grossfeld GD, Kassis A, Shinohara K, Roach M, Carroll PR. Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy. Urology. 2000;56:622–626
  2. Hinnen KA, Jan JB, van Roermund JG, et al. Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2009;
  3. Sahgal A, Roach Mr. Permanent prostate seed brachytherapy: a current perspective on the evolution of the technique and its application. Nat Clin Pract Urol. 2007;4:658–670
  4. Yu Y, Anderson LL, Li Z, et al. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine task group no. 64. Med Phys. 1999;26:2054–2076
  5. Holm HH, Juul N, Pedersen JF, Hansen H, Stroyer I. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol. 1983;130:283–286
  6. Blasko JC, Grimm PD, Ragde H. Brachytherapy and organ preservation in the management of carcinoma of the prostate. Semin Radiat Oncol. 1993;3:240–249
  7. Grimm PD, Blasko JC, Sylvester JE, Meier RM, Cavanagh W. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys. 2001;51:31–40
  8. Ragde H, Korb LJ, Elgamal AA, Grado GL, Nadir BS. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer. 2000;89:135–141
  9. Lee WR, Moughan J, Owen JB, Zelefsky MJ. The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States. Cancer. 2003;98:1987–1994
  10. Prestidge BR, Prete JJ, Buchholz TA, et al. A survey of current clinical practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys. 1998;40:461–465
  11. Kaplan ID, Holupka EJ, Meskell P, et al. Intraoperative treatment planning for radioactive seed implant therapy for prostate cancer. Urology. 2000;56:492–495
  12. Messing EM, Zhang JB, Rubens DJ, et al. Intraoperative optimized inverse planning for prostate brachytherapy: early experience. Int J Radiat Oncol Biol Phys. 1999;44:801–808
  13. Beaulieu L, Evans DA, Aubin S, et al. Bypassing the learning curve in permanent seed implants using state-of-the-art technology. Int J Radiat Oncol Biol Phys. 2007;67:71–77
  14. Nag S, Ciezki JP, Cormack R, et al. Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys. 2001;51:1422–1430
  15. Vicini FA, Kestin LL, Martinez AA. The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 1999;45:553–561
  16. Beyer DC, Shapiro RH, Puente F. Real-time optimized intraoperative dosimetry for prostate brachytherapy: a pilot study. Int J Radiat Oncol Biol Phys. 2000;48:1583–1589
  17. Wilkinson DA, Lee EJ, Ciezki JP, et al. Dosimetric comparison of pre-planned and or-planned prostate seed brachytherapy. Int J Radiat Oncol Biol Phys. 2000;48:1241–1244
  18. Gewanter RM, Wuu C, Laguna JL, Katz AE, Ennis RD. Intraoperative preplanning for transperineal ultrasound-guided permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;48:377–380
  19. Matzkin H, Kaver I, Stenger A, Agai R, Esna N, Chen J. Iodine-125 brachytherapy for localized prostate cancer and urinary morbidity: a prospective comparison of two seed implant methods-preplanning and intraoperative planning. Urology. 2003;62:497–502
  20. Woolsey J, Bissonette E, Schneider BF, Theodorescu D. Prospective outcomes associated with migration from preoperative to intraoperative planned brachytherapy: a single center report. J Urol. 2004;172:2528–2531
  21. Shah JN, Wuu CS, Katz AE, Laguna JL, Benson MC, Ennis RD. Improved biochemical control and clinical disease-free survival with intraoperative versus preoperative preplanning for transperineal interstitial permanent prostate brachytherapy. Cancer J. 2006;12:289–297
  22. Grado GL. Techniques to achieve optimal seed placement in salvage and primary brachytherapy for prostate cancer. Tech Urol. 2000;6:157–165
  23. Grado GL, Larson TR, Balch CS, et al. Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Int J Radiat Oncol Biol Phys. 1998;42:289–298
  24. Shanahan TG, Nanavati PJ, Mueller PW, Maxey RB. A comparison of permanent prostate brachytherapy techniques: preplan vs. hybrid interactive planning with postimplant analysis. Int J Radiat Oncol Biol Phys. 2002;53:490–496
  25. Zelefsky MJ, Yamada Y, Cohen G, et al. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique. Int J Radiat Oncol Biol Phys. 2000;48:601–608
  26. Raben A, Chen H, Grebler A, et al. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose. Int J Radiat Oncol Biol Phys. 2004;60:1631–1638
  27. Potters L, Calugaru E, Jassal A, Presser J. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?. Int J Radiat Oncol Biol Phys. 2006;65:1014–1019
  28. Stock RG, Stone NN, Lo YC. Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant. Tech Urol. 2000;6:95–98
  29. Stock RG, Stone NN, Wesson MF, DeWyngaert JK. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys. 1995;32:219–225
  30. Todor DA, Zaider M, Cohen GN, Worman MF, Zelefsky MJ. Intraoperative dynamic dosimetry for prostate implants. Phys Med Biol. 2003;48:1153–1171
  31. Lee EK, Zaider M. Intraoperative dynamic dose optimization in permanent prostate implants. Int J Radiat Oncol Biol Phys. 2003;56:854–861
  32. Jain AK, Zhou Y, Mustufa T, Burdette EC, Chirikjian GS, Fichtinger G. Matching and reconstruction of brachytherapy seeds using the Hungarian algorithm (MARSHAL). Med Phys. 2005;32:3475–3492
  33. Han BH, Wallner K, Merrick G, Butler W, Sutlief S, Sylvester J. Prostate brachytherapy seed identification on post-implant TRUS images. Med Phys. 2003;30:898–900
  34. Xue J, Waterman F, Handler J, Gressen E. Localization of linked 125I seeds in postimplant TRUS images for prostate brachytherapy dosimetry. Int J Radiat Oncol Biol Phys. 2005;62:912–919
  35. Meijer GJ, van den Berg HA, Hurkmans CW, Stijns PE, Weterings JH. Dosimetric comparison of interactive planned and dynamic dose calculated prostate seed brachytherapy. Radiother Oncol. 2006;80:378–384
  36. Su Y, Davis BJ, Herman MG, Robb RA. TRUS-fluoroscopy fusion for intraoperative prostate brachytherapy dosimetry. In: al. JDWe, editor. 14. IOS Press; 2006. p. 532–537.
  37. Su Y, Davis BJ, Furutani KM, Herman MG, Robb RA. Seed localization and TRUS-fluoroscopy fusion for intraoperative prostate brachytherapy dosimetry. Comput Aided Surg. 2007;12:25–34
  38. French D, Morris J, Keyes M, Goksel O, Salcudean S. Computing intraoperative dosimetry for prostate brachytherapy using TRUS and fluoroscopy. Acad Radiol. 2005;12:1262–1272
  39. Gong L, Cho PS, Han BH, et al. Ultrasonography and fluoroscopic fusion for prostate brachytherapy dosimetry. Int J Radiat Oncol Biol Phys. 2002;54:1322–1330
  40. Su Y, Davis BJ, Herman MG, Robb RA. Prostate brachytherapy seed localization by analysis of multiple projections: identifying and addressing the seed overlap problem. Med Phys. 2004;31:1277–1287
  41. Siewerdsen JH, Moseley DJ, Burch S, et al. Volume CT with a flat-panel detector on a mobile, isocentric C-arm: pre-clinical investigation in guidance of minimally invasive surgery. Med Phys. 2005;32:241–254
  42. Jaffray DA, Siewerdsen JH, Edmundson GK, Wong JW. Flat-panel cone-beam CT on a mobile isocentric C-arm for image-guided brachytherapy. Proc SPIE. 2002;4682:209–217
  43. Siewerdsen JH, Daly MJ, Bachar G, Moseley DJ. Multimode C-arm fluoroscopy, tomosynthesis, and cone-beam CT for image-guided interventions: from proof of principle to patient protocols. Proc SPIE. 2007;6510:65101A–651011
  44. Westendorp H, Hoekstra CJ, van’t Riet A, Minken AW, Immerzeel JJ. Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography-based dosimetry. Brachytherapy. 2007;6:231–237
  45. Blumenfeld P, Hata N, DiMaio S, et al. Transperineal prostate biopsy under magnetic resonance image guidance. A needle placement accuracy study. J Magn Reson Imaging. 2007;26:688–694
  46. Cormack RA, D’Amico AV, Hata N, Silverman S, Weinstein M, Tempany CM. Feasibility of transperineal prostate biopsy under interventional magnetic resonance guidance. Urology. 2000;56:663–664
  47. Aigner F, Pallwein L, Pelzer A, et al. Value of magnetic resonance imaging in prostate cancer diagnosis. World J Urol. 2007;25:351–359
  48. Shukla-Dave A, Hricak H, Kattan MW, et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int. 2007;99:786–793
  49. Clarke DH, Banks SJ, Wiederhorn AR, et al. The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants. Int J Radiat Oncol Biol Phys. 2002;52:903–910
  50. De Meerleer G, Villeirs G, Bral S, et al. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy. Radiother Oncol. 2005;75:325–333
  51. Tanaka O, Hayashi S, Matsuo M, et al. MRI-based preplanning in low-dose-rate prostate brachytherapy. Radiother Oncol. 2007;2:2
  52. Tempany C, Straus S, Hata N, Haker S. MR-guided prostate interventions. J Magn Reson Imaging. 2008;27:356–367
  53. Van Gellekom MP, Moerland MA, Battermann JJ, Lagendijk JJ. MRI-guided prostate brachytherapy with single needle method – a planning study. Radiother Oncol. 2004;71:327–332
  54. Hricak H, Jeffrey RB, Dooms GC, Tanagho EA. Evaluation of prostate size: a comparison of ultrasound and magnetic resonance imaging. Urol Radiol. 1987;9:1–8
  55. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol. 1991;145:984–987
  56. Rahmouni A, Yang A, Tempany CM, et al. Accuracy of in vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr. 1992;16:935–940
  57. Terris MK, McNeal JE, Stamey TA. Estimation of prostate cancer volume by transrectal ultrasound imaging. J Urol. 1992;147:855–857
  58. al-Rimawi M, Griffiths DJ, Boake RC, Mador DR, Johnson MA. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostatic volume. Br J Urol. 1994;74:596–600
  59. Tewari A, Indudhara R, Shinohara K, et al. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia. J Clin Ultrasound. 1996;24:169–174
  60. Sosna J, Rofsky NM, Gaston SM, DeWolf WC, Lenkinski RE. Determinations of prostate volume at 3-Tesla using an external phased array coil: comparison to pathologic specimens. Acad Radiol. 2003;10:846–853
  61. van As N, Parker C, de Souza N. Magnetic resonance imaging is the modality of choice for accurate assessment of prostate volume. Clin Oncol. 2007;19:S4
  62. Penner EA. Interventional MR with a mid-field open system. In:  Debatin JFA G editors. Interventional magnetic resonance imaging. Berlin: Springer-Verlag; 1998;p. 11–18
  63. Popowski Y, Hiltbrand E, Joliat D, Rouzaud M. Open magnetic resonance imaging using titanium–zirconium needles: improved accuracy for interstitial brachytherapy implants?. Int J Radiat Oncol Biol Phys. 2000;47:759–765
  64. Kooy HM, Cormack RA, Mathiowitz G, Tempany C, D’Amico AV. A software system for interventional magnetic resonance image-guided prostate brachytherapy. Comput Aided Surg. 2000;5:401–413
  65. D’Amico AV, Cormack R, Tempany CM, et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1998;42:507–515
  66. D’Amico A, Cormack R, Kumar S, Tempany CM. Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer. J Endourol. 2000;14:367–370
  67. D’amico AV, Tempany CM, Schultz D, et al. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology. 2003;62:1063–1067
  68. Landis DM, Schultz D, Cormack R, et al. Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy. Urology. 2005;65:750–754
  69. Thomas MD, Cormack R, Tempany CM, et al. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;47:905–908
  70. Nguyen PL, Chen MH, D’Amico AV, et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer. 2007;110:1485–1492
  71. Ficarra V, Cavalleri S, Novara G, Aragona M, Artibani W. Evidence from robot-assisted laparoscopic radical prostatectomy: a systematic review. Eur Urol. 2007;51:45–55discussion 56
  72. Wei Z, Wan G, Gardi L, Mills G, Downey D, Fenster A. Robot-assisted 3D-TRUS guided prostate brachytherapy: system integration and validation. Med Phys. 2004;31:539–548
  73. Fichtinger G, Fiene JP, Kennedy CW, et al. Robotic assistance for ultrasound-guided prostate brachytherapy. Med Image Anal. 2008;12:535–545
  74. Davies BL, Harris SJ, Dibble E. Brachytherapy – an example of a urological minimally invasive robotic procedure. Int J Med Robot. 2004;1:88–96
  75. Lagerburg V, Moerland MA, van Vulpen M, Lagendijk JJ. A new robotic needle insertion method to minimise attendant prostate motion. Radiother Oncol. 2006;80:73–77
  76. Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys. 2000;47:551–560
  77. Bentzen SM. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol. 2005;6:112–117
  78. Zelefsky MJ, Cohen G, Zakian KL, et al. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. Cancer J. 2000;6:249–255
  79. Mizowaki T, Cohen GN, Fung AY, Zaider M. Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int J Radiat Oncol Biol Phys. 2002;54:1558–1564
  80. Hoskin PJ, Carnell DM, Taylor NJ, et al. Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. Int J Radiat Oncol Biol Phys. 2007;68:1065–1071
  81. Yamaguchi T, Lee J, Uemura H, et al. Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy. Eur J Nucl Med Mol Imaging. 2005;32:742–748
  82. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39:990–995
  83. Nakanouchi T, Okihara K, Kojima M, et al. Possible use of transrectal power Doppler imaging as an indicator of microvascular density of prostate cancer. Urology. 2001;58:573–577
  84. Goossen TE, de la Rosette JJ, Hulsbergen-van de Kaa CA, van Leenders GJ, Wijkstra H. The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol. 2003;43:124–131

PII: S0167-8140(09)00670-7

doi: 10.1016/j.radonc.2009.12.012

Radiotherapy & Oncology
Volume 94, Issue 1 , Pages 12-23 , January 2010

Article Tools

* Image Usage & Resolution